CME/CE Deep Dive into 5: Your Questions on Menopausal Vasomotor Symptoms

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/dd5-your-questions-on-menopausal-vasomotor-symptoms-9542SummaryDr. Leana Wen guides Dr. Genevieve Neal-Perry through five of your most common questions on menopausal VMS. Get a better understanding of the evolution in the science surrounding the biology of menopause, and discuss new and emerging non-hormonal treatment options for women with menopausal hot flashes and night sweats. Keep the conversation going with this, the third podcast in the series.Learning ObjectivesUpon completion of this activity, learners should be able to:Discuss the biology of menopausal vasomotor symptoms (VMS)Integrate new and emerging agents into the treatment of women with menopausal VMS, based on patient characteristics and preferencesThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours, which includes 0 hours of pharmacology.For additional information about the accreditation of this program, please contact NACE at [email protected] of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis educational activity is supported by an independent medical educational grant from Astellas Pharma Global Development, Inc.Please visit  http://naceonline.com to engage in more live and on demand CME/CE content.